Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Lantern Pharma Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +3 vs. Q2 2021
- Shares held
- 1.40M
- +53.9K (+4.0%) vs. Q2 2021
- Total value
- $15.7M
- −$4.00M (−20.4%) vs. Q2 2021
- New holders
- 5
- 10 more added
- Sold out
- 2
- 6 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LTRN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $12.0M |
| Q1 2026 | 33 | $2.87M |
| Q4 2025 | 33 | $6.91M |
| Q3 2025 | 30 | $9.89M |
| Q2 2025 | 35 | $7.11M |
| Q1 2025 | 32 | $8.62M |
| Q4 2024 | 32 | $8.00M |
| Q3 2024 | 31 | $4.90M |
| Q2 2024 | 39 | $6.01M |
| Q1 2024 | 34 | $9.75M |
| Q4 2023 | 30 | $4.94M |
| Q3 2023 | 27 | $3.93M |
| Q2 2023 | 25 | $6.50M |
| Q1 2023 | 21 | $5.23M |
| Q4 2022 | 23 | $5.40M |
| Q3 2022 | 26 | $6.84M |
| Q2 2022 | 26 | $8.06M |
| Q1 2022 | 25 | $10.4M |
| Q4 2021 | 33 | $13.1M |
| Q3 2021 | 25 | $15.7M |
| Q2 2021 | 22 | $19.7M |
| Q1 2021 | 24 | $25.5M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Lantern Pharma Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Harbour Investments, Inc. | 31 | $0 | 0.00% | −14−31.1% | Reduced |
| Steward Partners Investment Advisory, LLC | 300 | $3.00K | 0.00% | +50+20.0% | Added |
| Tower Research Capital LLC (TRC) | 530 | $6.00K | 0.00% | +178+50.6% | Added |
| AdvisorNet Financial, Inc | 500 | $6.00K | 0.00% | +500 | New |
| Wells Fargo & Company | 953 | $11.0K | 0.00% | −6,470−87.2% | Reduced |
| Spire Wealth Management | 1,050 | $12.0K | 0.00% | 00.0% | Unchanged |
| Bank Julius Baer & Co. Ltd, Zurich | 1,500 | $17.0K | 0.00% | +473+46.1% | Added |
| US Bancorp | 2,000 | $22.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,770 | $31.0K | 0.00% | +1,770+177.0% | Added |
| Bank of America Corp | 5,603 | $62.0K | 0.00% | +3,412+155.7% | Added |
| UBS Group AG | 7,677 | $86.0K | 0.00% | −567−6.9% | Reduced |
| Susquehanna International Group, LLP | 10,909 | $122.0K | 0.00% | +10,909 | New |
| Northern Trust Corp | 12,629 | $141.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 12,688 | $142.0K | 0.00% | +12,688 | New |
| BlackRock Inc. | 23,074 | $258.0K | 0.00% | −2,043−8.1% | Reduced |
| State Street Corp | 25,567 | $286.0K | 0.00% | +25,567 | New |
| Raymond James & Associates | 25,879 | $289.0K | 0.00% | +25,879 | New |
| Bank of New York Mellon Corp | 26,765 | $299.0K | 0.00% | 00.0% | Unchanged |
| Wolff Wiese Magana LLC | 35,316 | $395.0K | 0.28% | +6,997+24.7% | Added |
| Redmond Asset Management, LLC | 47,442 | $530.0K | 0.17% | +1,942+4.3% | Added |
| Morgan Stanley | 47,928 | $535.0K | 0.00% | −4,376−8.4% | Reduced |
| Geode Capital Management, LLC | 57,043 | $637.0K | 0.00% | +1,564+2.8% | Added |
| GWM Advisors LLC | 155,859 | $1.74M | 0.04% | +4,543+3.0% | Added |
| Vanguard Group Inc | 270,820 | $3.03M | 0.00% | +1,391+0.5% | Added |
| Corriente Advisors, LLC | 625,873 | $7.00M | 13.51% | −30,491−4.6% | Reduced |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −13−100.0% | Sold out |